These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 35022034)

  • 1. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
    Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
    BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
    Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
    BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study.
    Roodenrijs NMT; van der Goes MC; Welsing PMJ; van Oorschot EPC; Nikiphorou E; Nijhof NC; Tekstra J; Lafeber FPJG; Jacobs JWG; van Laar JM; Geenen R
    Rheumatology (Oxford); 2021 Nov; 60(11):5105-5116. PubMed ID: 33560301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Health Care Professionals' Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?
    van Heuckelum M; Hebing RCF; Vandeberg L; Linn AJ; Flendrie M; Nurmohamed MT; van Dulmen S; van den Ende CHM; van den Bemt BJF
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):364-373. PubMed ID: 32166901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivational interviewing to support medication adherence in older patients: Barriers and facilitators for implementing in hospital setting according to healthcare professionals.
    Temedda MN; Haesebaert J; Viprey M; Schott AM; Dima AL; Papus M; Schneider MP; Novais T
    Patient Educ Couns; 2024 Jul; 124():108253. PubMed ID: 38507931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
    Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
    Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and barriers to adherence in the initiation phase of Disease-modifying Antirheumatic Drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment.
    Pasma A; van 't Spijker A; Luime JJ; Walter MJ; Busschbach JJ; Hazes JM
    J Rheumatol; 2015 Mar; 42(3):379-85. PubMed ID: 25512473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study.
    Heidari P; Cross W; Weller C; Team V; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Sep; 22(9):1695-1705. PubMed ID: 31322831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranking facilitators and barriers of medication adherence by patients with inflammatory arthritis: a maximum difference scaling exercise.
    Voshaar MJH; Vriezekolk JE; van Dulmen AM; van den Bemt BJF; van de Laar MAFJ
    BMC Musculoskelet Disord; 2021 Jan; 22(1):21. PubMed ID: 33407344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
    Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
    BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study.
    Hazlewood GS; Loyola-Sanchez A; Bykerk V; Hull PM; Marshall D; Pham T; Barber CEH; Barnabe C; Sirois A; Pope J; Schieir O; Richards D; Proulx L; Bartlett SJ
    Rheumatology (Oxford); 2022 Feb; 61(2):606-616. PubMed ID: 33878168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare professionals' perspectives on facilitators of and barriers to CKD management in primary care: a qualitative study in Singapore clinics.
    Ramakrishnan C; Tan NC; Yoon S; Hwang SJ; Foo MWY; Paulpandi M; Gun SY; Lee JY; Chang ZY; Jafar TH
    BMC Health Serv Res; 2022 Apr; 22(1):560. PubMed ID: 35473928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considering health literacy in cardiovascular disease management: a qualitative study on healthcare professionals' and patients' perspectives.
    Perrin A; Damiolini E; Schott AM; Zermati J; Bravant E; Delahaye F; Dima AL; Haesebaert J
    BMC Health Serv Res; 2022 Sep; 22(1):1121. PubMed ID: 36064395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy.
    Peter ME; Zuckerman AD; DeClercq J; Choi L; James C; Cooper K; Choi J; Nadler M; Tanner SB
    J Manag Care Spec Pharm; 2021 Jul; 27(7):882-890. PubMed ID: 34185565
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome measures for young people with adolescent idiopathic scoliosis: A qualitative exploration of healthcare professionals' perceptions and practices.
    Alamrani S; Gardner A; Falla D; Russell E; Rushton AB; Heneghan NR
    PLoS One; 2024; 19(1):e0297339. PubMed ID: 38277344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
    McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
    J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
    Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
    BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregivers' and healthcare professionals' perspective of barriers and facilitators to health service access for asthmatic children: a qualitative study.
    Ardura-Garcia C; Blakey JD; Cooper PJ; Romero-Sandoval N
    BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34949576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature.
    Salt E; Frazier SK
    Orthop Nurs; 2010; 29(4):260-75. PubMed ID: 20664466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.